Progesterone as Luteal Support in Frozen IVF Natural Cycles

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
InfertilityEmbryo Transfer
Interventions
DRUG

Progesterone vaginal tablet

The study drug is progesterone 100 mg administrated as a vaginal tablet three times daily.

Trial Locations (1)

S-41345

RECRUITING

Department of Reproductive Medicine, Gothenburg

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Vastra Gotaland Region

OTHER_GOV